Leaflet VACCIN MENINGOCOCIC POLIZAHARIDIC A+C lyophilisate and solvent for suspension for injection
Indicated for: prevention of meningococcal disease
Route of administration: injectable
Substance: polysaccharide meningococcal vaccine (vaccine)
ATC: J07AH03 (Antiinfectives for systemic use | Bacterial vaccines | Meningococcal vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The meningococcal polysaccharide vaccine is used to prevent infections caused by Neisseria meningitidis, a bacterium that can cause meningitis and septicemia. The vaccine contains purified capsular polysaccharides from multiple serogroups of the bacterium, such as A, C, W, and Y, which stimulate the immune system to produce specific antibodies against these serogroups.
The vaccine is administered subcutaneously or intramuscularly, usually in a single dose, and is recommended for individuals traveling to endemic areas, those at increased risk of infection (such as students living in dormitories), or during outbreaks.
Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.
The meningococcal polysaccharide vaccine is an important preventive measure for reducing the incidence of meningococcal diseases, helping to protect vulnerable populations and prevent outbreaks.
General data about VACCIN MENINGOCOCIC POLIZAHARIDIC A+C
- Substance: polysaccharide meningococcal vaccine
- Date of latest medicines list: 01-07-2013
- Product code: W13389002
- Pharmaceutical form: lyophilisate and solvent for suspension for injection
- Quantity: 10
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.